Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 11
2009 10
2010 7
2011 2
2012 4
2013 2
2014 2
2015 1
2017 1
2018 2
2019 3
2020 2
2021 2
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention.
Thazhackavayal Baby B, Kulkarni AM, Gayam PKR, Harikumar KB, Aranjani JM. Thazhackavayal Baby B, et al. Among authors: harikumar kb. Arch Biochem Biophys. 2024 Apr;754:109952. doi: 10.1016/j.abb.2024.109952. Epub 2024 Mar 1. Arch Biochem Biophys. 2024. PMID: 38432565 Free article. Review.
Targeting acid ceramidase enhances antitumor immune response in colorectal cancer.
Vijayan Y, James S, Viswanathan A, Aparna JS, Bindu A, Namitha NN, Anantharaman D, Babu Lankadasari M, Harikumar KB. Vijayan Y, et al. Among authors: harikumar kb. J Adv Res. 2023 Dec 21:S2090-1232(23)00403-4. doi: 10.1016/j.jare.2023.12.013. Online ahead of print. J Adv Res. 2023. PMID: 38142035 Free article.
Sphingosine 1-phosphate signaling during infection and immunity.
Mohammed S, Bindu A, Viswanathan A, Harikumar KB. Mohammed S, et al. Among authors: harikumar kb. Prog Lipid Res. 2023 Nov;92:101251. doi: 10.1016/j.plipres.2023.101251. Epub 2023 Aug 24. Prog Lipid Res. 2023. PMID: 37633365 Review.
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma.
Swetha M, Keerthana CK, Rayginia TP, Nath LR, Haritha NH, Shabna A, Kalimuthu K, Thangarasu AK, Aiswarya SU, Jannet S, Pillai S, Harikumar KB, Sundaram S, Anto NP, Wu DH, Lankalapalli RS, Towner R, Isakov N, Deepa SS, Anto RJ. Swetha M, et al. Among authors: harikumar kb. Pharmaceuticals (Basel). 2022 May 22;15(5):636. doi: 10.3390/ph15050636. Pharmaceuticals (Basel). 2022. PMID: 35631464 Free PMC article.
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.
Arndt C, Bergmann R, Striese F, Merkel K, Máthé D, Loureiro LR, Mitwasi N, Kegler A, Fasslrinner F, González Soto KE, Neuber C, Berndt N, Kovács N, Szöllősi D, Hegedűs N, Tóth G, Emmermann JP, Harikumar KB, Kovacs T, Bachmann M, Feldmann A. Arndt C, et al. Among authors: harikumar kb. Cancers (Basel). 2022 Apr 14;14(8):1996. doi: 10.3390/cancers14081996. Cancers (Basel). 2022. PMID: 35454902 Free PMC article.
Editorial: Targeting Pancreatic Cancer: Strategies and Hopes.
Manu KA, Harikumar KB, Ishimoto T. Manu KA, et al. Among authors: harikumar kb. Front Oncol. 2022 Mar 31;12:873682. doi: 10.3389/fonc.2022.873682. eCollection 2022. Front Oncol. 2022. PMID: 35433449 Free PMC article. No abstract available.
DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.
Kurani H, Razavipour SF, Harikumar KB, Dunworth M, Ewald AJ, Nasir A, Pearson G, Van Booven D, Zhou Z, Azzam D, Wahlestedt C, Slingerland J. Kurani H, et al. Among authors: harikumar kb. Clin Cancer Res. 2022 May 2;28(9):1948-1965. doi: 10.1158/1078-0432.CCR-21-1299. Clin Cancer Res. 2022. PMID: 35135840 Free PMC article.
54 results